Bookmark

Add to MyYahoo RSS

Roth Capital Partners News

News on Roth Capital Partners continually updated from thousands of sources around the net.

2 hrs ago | Freshnews

MoSys to Participate at the ROTH Semiconductor Corporate Access Day on September 3, 2014

MoSys , a leader in semiconductor solutions that enable fast, intelligent data access for network and communications systems, today announced that Len Perham, chief executive officer, and Jim Sullivan, chief financial officer, will participate at the ROTH Semiconductor Corporate Access Day and will be available to meet with investors on Wednesday, ... (more)

Comment?

Related Topix: Semiconductors, Startups, Monolithic System Technology, Electronics, MoSys, San Francisco County, CA, San Francisco, CA, Investment Banking, Financial Services

Tue Aug 19, 2014

Hispanic Business

ROTH Capital Partners to Host 5th Annual Semiconductor Corporate...

'We believe the semiconductor sector presents a compelling opportunity for small/mid-cap growth investors.

Comment?

Related Topix: Investment Banking, Financial Services, Applied Micro Circuits, Startups, Cloud Computing, Science / Technology

Freshnews

ROTH Capital Partners to Host 5th Annual Semiconductor Corporate...

ROTH Capital Partners , www.roth.com , a full service investment bank focused on serving emerging growth companies and their investors, today announced it will host its 5th Annual Semiconductor Corporate Access Day on Wednesday, September 3, 2014 at the St. Regis Hotel in San Francisco, Calif.

Comment?

Related Topix: Investment Banking, Financial Services, San Francisco County, CA, San Francisco, CA, Applied Micro Circuits, Startups, Cloud Computing, Science / Technology

Thu Aug 14, 2014

Hispanic Business

ROTH Capital Partners Expands Resources Practice with Addition of...

'John is our second dedicated research analyst in the resources sector, joining .

Comment?

Related Topix: Financial Services, Investment Banking

Wed Jul 30, 2014

GlobeNewswire

Bio Blast Pharma Prices Initial Public Offering of $35,200,000 of Ordinary Shares

Bio Blast Pharma Ltd. , a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases, announced today the pricing of its initial public offering of 3,200,000 ordinary shares at an initial public offering price of $11.00 per share.

Comment?

Related Topix: Financial Services, Oppenheimer Holdings, Investment Banking, Securities and Exchange Commission, Corporate / Securities Law, Law, Attention

Fri Jul 25, 2014

InvestorIdeas.com

ROTH Capital's Debjit Chattopadhyay: Marriage of Diagnostics to New Therapies Breeds Biotech Winners

July 25, 2014 Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease.

Comment?

Related Topix: Biotech, Science / Technology, Investment Banking, Financial Services, Oncology, Medicine

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••